share_log

Denali Therapeutics(DNLI.US) Director Sells US$1.9 Million in Common Stock

moomoo News ·  Apr 2 18:49

$Denali Therapeutics (DNLI.US)$ Director Krognes Steve E. sold 92,500 shares of Common Stock on Apr 1, 2024 at an average price of $20.5 for a total value of $1.9 million.

1712098153608762246.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment